Vol.41,Issue 3,June 2020

Genomic profiling in gynaecological oncology: the future is now!

Development of lymphangiosarcoma after pelvic radiation therapy for uterine cervical cancer: A case report and literature review

Endometrial stromal nodule: report of 8 cases and literature review

Prognostic value of Foxp3+ regulatory T cells in endometrial cancer: a meta-analysis

Sustained effects of theory-based physical activity intervention for socioeconomically diverse obese endometrial cancer survivors: A Longitudinal analysis

Morphological analysis of peritoneal dissemination of ovarian cancer based on levels of carbonyl reductase 1 expression

Ten-year survival in patients with endometrial adenoacanthoma and endometrial adenocarcinoma with malignant squamous cell differentiation

Bevacizumab in combination with metronomic oral cyclophosphamide: an effective and well-tolerated treatment for patients with recurrent ovarian cancer

Is the Risk of Malignancy Index a predictive tool for preoperative differentiation between borderline ovarian tumor and ovarian cancer?

Decreased expression of estrogen receptors alpha and beta in peripheral blood lymphocytes from the endometrial cancer patients and women with endometriosis

Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer (TGCU 104 study)

The effect of six scheduled cycles of neoadjuvant chemotherapy on prognosis in advanced ovarian cancer

The outcomes of fertility sparing surgery in epithelial ovarian cancer

Epidemiologic profile of benign versus oncologic gynecology populations: similar procedures, different patients

Likelihood of incidental finding of gynecological cancer in women undergoing hysterectomy for benign indications

Sentinel lymph node mapping with carbon nanoparticles in endometrial cancer

Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older

Ovarian conservation without postoperative radiation improved survival outcomes in patients with stage i uterine leiomyosarcoma

Oleic acid promotes the development of endometrial cancer by up-regulating KLF4 expression

PTEN and CD146 expression in endometrioid adenocarcinoma

Is appendectomy a must for borderline and invasive mucinous ovarian tumour?

Clear-cell carcinoma of the endometriu type I or type II endometrial carcinoma?

Survival-associated transcriptome analysis in ovarian cancer

Preserving fertility in patients with granulosa cell tumors of the ovary

Juvenile ovarian mature teratoma with malignant transformation diagnosed after laparoscopic surgery: A case report

Intrapelvic low grade leiomyosarcoma with good prognosis

A spindle cell ovarian sarcoma report

Postmenopausal recurrent retrovaginal extramural gastrointestinal stromal tumor: a case report

Safe fertility-preserving management in a young woman with endometrial cancer

Is there a difference between synchronous multiple primary cancer and metastasis cancer?

Malignancy-transformed mature cystic teratoma surgical treatment requires comprehensive staging procedures including pelvic/para-aortic lymphadenectomy

Neoadjuvant chemotherapy followed by radical surgery for Stage IB2 cervical cancer in pregnancy

Case series of uterine smooth muscle tumors of uncertain malignant potential (STUMP)